Milošević, Ivana (58456808200)Ivana (58456808200)MiloševićJovanović, Jaroslava (57220948637)Jaroslava (57220948637)JovanovićStevanović, Olja (57201195181)Olja (57201195181)Stevanović2025-07-022025-07-022020https://doi.org/10.3855/jidc.13840https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097916070&doi=10.3855%2fjidc.13840&partnerID=40&md5=63f87e25acf571249b4e7a78e788c44chttps://remedy.med.bg.ac.rs/handle/123456789/12373We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor. © 2020 Journal of Infection in Developing Countries. All rights reserved.AgammaglobulinemiaConvalescent plasmaCOVID-19IL-6 inhibitorAtypical course of COVID-19 in patient with Bruton agammaglobulinemia